Sign in
Taking peopleNo phase

Shanghai Eye Study for Adults

Key facts

Who runs it
Shanghai Eye Disease Prevention and Treatment Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
1,000,000 people, planned
Started
1 Jan 2016
Expected to end
30 Nov 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • spectacles
Record updated
24 May 2022

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • shanghai residents aged ≥18 years old

Who cannot take part

  • cognitive and/or mobility disorders; non-shanghai residents; younger than 18 years old

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Blindness and visual impairment severely impact the visual health and life quality of people, particularly the 2.566 million senior citizens aged at 65 and above in Shanghai. The main reason is uncorrected refractive error, of which, 62.1% can be solved through refractive correction. For this reason, the uncorrected refractive errors of 154,000 senior citizens in Shanghai can be taken as a priority among the public health issues to prevent blindness. Now, with the aim to reduce the prevalence rate of blindness and visual impairment, it is planned to establish a public health service mechanism in terms of refractive error screening and correction for the elderly by relying on Shanghai's three-level (city-district-community) eye diseases prevention network, using proper refractive correction technology, and moving related services forward to communities in order to screen, identity, and correct blindness and visual impairment caused by refractive errors as early as possible.

The 2 groups in the trial

  • corrected refractive errorTreatment being tested

    Treatment: spectacles

  • uncorrected refractive errorNo study treatment, for comparison

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT03455478, who can take part
Record updated
24 May 2022